The learning curve for robot-assisted partial nephrectomy: Impact of surgical experience on perioperative outcomes
12 auth.
A. Larcher,
B. Peyronnet,
G. Naeyer,
F. Muttin,
Z. Khene,
P. Schatteman,
...
F. D’hondt,
C. Ferreiro,
U. Capitanio,
F. Montorsi,
K. Bensalah,
A. Mottrie
|
6 |
2018 |
6
2018
|
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histological subtype matter?
14 auth.
S. Berg,
D. D’andrea,
M. Vetterlein,
A. Cole,
S. Fletcher,
M. Krimphove,
M. Marchese,
S. Lipsitz,
G. Sonpavde,
J. Noldus,
...
S. Shariat,
A. Kibel,
Q. Trinh,
M. Mossanen
|
5 |
2019 |
5
2019
|
Xp11.2 translocation renal cell carcinoma
7 auth.
O. Neagu,
A. Petrescu,
G. Berdan,
L. Mitrache,
S. Varban,
P. Argani,
...
V. Jinga
|
5 |
2018 |
5
2018
|
Likert vs. PI-RADS v2: A comparison of two radiological scoring systems for detection of clinically significant prostate cancer
24 auth.
C. Khoo,
D. Eldred-Evans,
J. Jaenicke,
M. Tanaka,
T. Shah,
S. Miah,
M. Connor,
D. Reddy,
J. Sethi,
A. Forde,
...
H. Bhola-Stewart,
Andrew Smith,
James Carton,
J. Lloyd,
E. Mannion,
F. Hosking-Jervis,
Emma Cullen,
R. Cartwright,
Martin Clark,
M. Arya,
D. Hrouda,
M. Winkler,
H. Tam,
H. Ahmed
|
4 |
2019 |
4
2019
|
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration resistant prostate cancer
12 auth.
B. Grubmüller,
D. Senn,
G. Kramer,
P. Baltzer,
D. D’andrea,
H. Eidherr,
...
A. Haug,
W. Wadsak,
S. Pfaff,
M. Hacker,
S. Shariat,
M. Hartenbach
|
4 |
2019 |
4
2019
|
Tumor associated macrophages promote bladder tumor growth through PI3k/AKT signal induced by collagen
Q. Shi,
L. Jiakun,
J. Kun,
Y. Lu,
W. Qiang
|
4 |
2019 |
4
2019
|
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
8 auth.
A. Meyer,
S. Rowe,
M. Carducci,
S. Denmeade,
M. Markowski,
M. Pomper,
...
M. Allaf,
M. Gorin
|
4 |
2019 |
4
2019
|
Prognostic significance of controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients
8 auth.
Hiroaki Suzuki,
K. Takemura,
Masaya Ito,
Y. Nakanishi,
M. Kataoka,
K. Sakamoto,
...
K. Tobisu,
F. Koga
|
3 |
2019 |
3
2019
|
Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma
10 auth.
A. Pastore,
Y. Salhi,
A. Fuschi,
G. Velotti,
A. Martoccia,
L. Capone,
...
F. Fazi,
V. Petrozza,
G. Palleschi,
A. Carbone
|
3 |
2018 |
3
2018
|
The changing face of urologic oncologic surgery from 2000-2018 (63 141 patients) - impact of robotics
I. Gill,
G. Cacciamani
|
3 |
2019 |
3
2019
|
